NovaBay Pharmaceuticals (NBY) PT Raised to $3.75 at Ascendiant Capital
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $0.72 -6.49%
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 41
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 41
Trade Now!
Join SI Premium – FREE
Ascendiant Capital analyst Edward Woo raised the price target on NovaBay Pharmaceuticals (NYSE: NBY) to $3.75 (from $3.50) while maintaining a Buy rating.
You May Also Be Interested In
- Nomura/Instinet Upgrades Wipro Ltd. (WPRO:IN) (WIT) to Neutral
- Movida Participacoes SA (MOVI3:BZ) PT Lowered to R$20 at Morgan Stanley
- ERO Copper (ERO:CN) (ERRPF) PT Raised to Cdn$27.50 at Canaccord Genuity
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
